S'abonner

New mechanism underlying IL-31–induced atopic dermatitis - 04/05/18

Doi : 10.1016/j.jaci.2017.12.1002 
Jianghui Meng, PhD a, b, , Masaki Moriyama, PhD c, Micha Feld, PhD d, Joerg Buddenkotte, MD, PhD e, f, Timo Buhl, MD g, Attila Szöllösi, PhD b, Jingming Zhang, PhD h, Paul Miller, PhD h, Andre Ghetti, PhD h, Michael Fischer, MD i, Peter W. Reeh, MD j, Chunxu Shan, PhD a, b, Jiafu Wang, PhD a, Martin Steinhoff, MD, PhD b, c, e, f,
a International Center for Neurotherapeutics, Dublin City University, Dublin, Ireland 
b Department of Dermatology and UCD Charles Institute for Translational Dermatology, Dublin, Ireland 
c Department of Dermatology, University of California, San Francisco, Calif 
d Department of Dermatology, University Hospital Düsseldorf, Dusseldorf, Germany 
e Department of Dermatology and Venereology, Hamad Medical Corporation, Qatar University, Doha, Qatar 
f School of Medicine, Weill Cornell University–Qatar and Qatar University, Doha, Qatar 
g Department of Dermatology, University Medical Center Göttingen, Gottingen, Germany 
h AnaBios, San Diego, Calif 
i Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria 
j Institut für Physiologie & Pathophysiologie, Universität Erlangen-Nürnberg, Erlangen, Germany 

Corresponding author: Jianghui Meng, PhD, International Centre for Neurotherapeutics, Dublin City University, Glasnevin Avenue, Dublin 9, Dublin, Ireland.International Centre for NeurotherapeuticsDublin City UniversityGlasnevin Avenue, Dublin 9DublinIrelandMartin Steinhoff, MD, PhD, Department of Dermatology, PO Box 3050, Hamad Medical Corporation, Rumailah Hospital, Qatar University, Doha, Qatar.Department of DermatologyPO Box 3050, Hamad Medical CorporationRumailah HospitalQatar UniversityDohaQatar

Abstract

Background

TH2 cell–released IL-31 is a critical mediator in patients with atopic dermatitis (AD), a prevalent and debilitating chronic skin disorder. Brain-derived natriuretic peptide (BNP) has been described as a central itch mediator. The importance of BNP in peripheral (skin-derived) itch and its functional link to IL-31 within the neuroimmune axis of the skin is unknown.

Objective

We sought to investigate the function of BNP in the peripheral sensory system and skin in IL-31–induced itch and neuroepidermal communication in patients with AD.

Methods

Ca2+ imaging, immunohistochemistry, quantitative real-time PCR, RNA sequencing, knockdown, cytokine/phosphokinase arrays, enzyme immune assay, and pharmacologic inhibition were performed to examine the cellular basis of the IL-31–stimulated, BNP-related itch signaling in dorsal root ganglionic neurons (DRGs) and skin cells, transgenic AD-like mouse models, and human skin of patients with AD and healthy subjects.

Results

In human DRGs we confirmed expression and co-occurrence of oncostatin M receptor β subunit and IL-31 receptor A in a small subset of the neuronal population. Furthermore, IL-31 activated approximately 50% of endothelin-1–responsive neurons, and half of the latter also responded to histamine. In murine DRGs IL-31 upregulated Nppb and induced soluble N-ethylmaleimide–sensitive factor activating protein receptor–dependent BNP release. In Grhl3PAR2/+ mice house dust mite–induced severe AD-like dermatitis was associated with Nppb upregulation. Lesional IL-31 transgenic mice also exhibited increased Nppb transcripts in DRGs and the skin; accordingly, skin BNP receptor levels were increased. Importantly, expression of BNP and its receptor were increased in the skin of patients with AD. In human skin cells BNP stimulated a proinflammatory and itch-promoting phenotype.

Conclusion

For the first time, our findings show that BNP is implicated in AD and that IL-31 regulates BNP in both DRGs and the skin. IL-31 enhances BNP release and synthesis and orchestrates cytokine and chemokine release from skin cells, thereby coordinating the signaling pathways involved in itch. Inhibiting peripheral BNP function might be a novel therapeutic strategy for AD and pruritic conditions.

Le texte complet de cet article est disponible en PDF.

Key words : Atopic dermatitis, pruritogens, brain-derived natriuretic peptide, pruritus, skin, dorsal root ganglion, keratinocytes, dendritic cells, soluble N-ethylmaleimide–sensitive factor activating protein receptors

Abbreviations used : AD, BNP, CGRP, DRG, ET-1, FPKM, GAPDH, GSK3, hDC, HDM, hDRG, H&E, hKC, IL-31RA, JNK, mDRG, MMP9, NeuN, NPR1, NPR2, OSMRβ, PGP9.5, RNA-Seq, shRNA, SNAP-25, SNARE, SP, TG, Tg, V1, V7, VAMP, WT


Plan


 Science Foundation Ireland is thanked for funding this research through a Starting Investigator Award (to J.M.; grant no. 15/SIRG/3508T), a Principle Investigator Award (to M.S.) and a Career Development Award (13/CDA/2093 to J.W.). M.S. received Excellence seed funding from Hamad Medical Corporation, Qatar.
 Disclosure of potential conflict of interest: J. Meng has received a grant from Science Foundation Ireland (15/SIRG/3508T). M. Moriyama has received a grant from the National Institutes of Health. J. Zhang, P. Miller, and A. Ghetti have received fees for service from UCD. J. Wang has received a grant from Science Foundation Ireland (13/CDA/2093). The rest of the authors declare that they have no relevant conflicts of interest.


© 2018  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 141 - N° 5

P. 1677 - mai 2018 Retour au numéro
Article précédent Article précédent
  • Epidermal lipid composition, barrier integrity, and eczematous inflammation are associated with skin microbiome configuration
  • Hansjörg Baurecht, Malte C. Rühlemann, Elke Rodríguez, Frederieke Thielking, Inken Harder, Anna-Sophie Erkens, Dora Stölzl, Eva Ellinghaus, Melanie Hotze, Wolfgang Lieb, Sheng Wang, Femke-Anouska Heinsen-Groth, Andre Franke, Stephan Weidinger
| Article suivant Article suivant
  • Eosinophilic esophagitis (EoE) genetic susceptibility is mediated by synergistic interactions between EoE-specific and general atopic disease loci
  • Lisa J. Martin, Hua He, Margaret H. Collins, J.Pablo Abonia, Joceyln M. Biagini Myers, Michael Eby, Hanna Johansson, Leah C. Kottyan, Gurjit K. Khurana Hershey, Marc E. Rothenberg

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.